ストックスクリーナーアプリを入手
5.03
5.18%
-0.275
アフターアワーズ：
5.07
0.04
+0.80%
前日終値:
$5.305
開ける：
$5.225
24時間の取引高:
8.33M
Relative Volume:
1.55
時価総額：
$1.20B
収益：
-
当期純損益:
$-252.18M
株価収益率:
-4.7453
EPS:
-1.06
ネットキャッシュフロー:
$-185.29M
1週間 パフォーマンス:
+16.44%
1か月 パフォーマンス:
+65.46%
6か月 パフォーマンス:
+204.85%
1年 パフォーマンス:
+23.89%
1日の値動き範囲:
$4.81
$5.33
1週間の範囲:
$4.195
$6.55
52週間の値動き範囲:
$1.26
$7.30
Sana Biotechnology Inc Stock (SANA) Company Profile
名前
Sana Biotechnology Inc
セクター
電話
(206) 701-7914
住所
188 EAST BLAINE STREET, SUITE 400, SEATTLE
SANA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
5.03 | 1.36B | 0 | -252.18M | -185.29M | -1.06 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-24 | 開始されました | Wedbush | Outperform |
| 2025-07-03 | 再開されました | Morgan Stanley | Overweight |
| 2025-03-18 | アップグレード | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | 開始されました | Jefferies | Buy |
| 2025-01-08 | アップグレード | TD Cowen | Hold → Buy |
| 2024-11-05 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | 開始されました | Rodman & Renshaw | Buy |
| 2024-01-16 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-09-05 | 開始されました | Citigroup | Buy |
| 2023-08-14 | 開始されました | TD Cowen | Market Perform |
| 2023-05-02 | 開始されました | H.C. Wainwright | Neutral |
| 2021-03-01 | 開始されました | BofA Securities | Buy |
| 2021-03-01 | 開始されました | Goldman | Neutral |
| 2021-03-01 | 開始されました | JP Morgan | Neutral |
| 2021-03-01 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Sana Biotechnology Inc (SANA) 最新ニュース
Sana Biotech Fights Investor Fraud Claims Over Trial Data - Law360
Will Sana Biotechnology Inc. stock maintain momentum in 2025 - newser.com
Real time breakdown of Sana Biotechnology Inc. stock performance2025 EndofYear Setup & Expert Verified Movement Alerts - newser.com
Comparing Sana Biotechnology Inc. in custom built stock radarsEntry Point & High Return Stock Watch Alerts - newser.com
Sana Biotechnology: Scope Goes Beyond HIP-Modified Pancreatic Islet Cells For T1D - Seeking Alpha
Sana Biotechnology: A Big Winner In Waiting? Maybe, But It Won't Happen Overnight (SANA) - Seeking Alpha
Sana Biotechnology (SANA) Stock Skyrockets on ‘100-Bagger’ Hype – Experts Debate What’s Next - ts2.tech
Exclusive BAC Article: Sana Biotechnology; Positive 6-Month Initial POC Type 1 Diabetes Data UP421, Additional Results 2nd Half 2025, SC291 And SC262 Data 2025 And Catalysts (NASDAQ:SANA) - Seeking Alpha
Sana Biotech Shares Skyrocket on 100x Hype – What’s Behind the Rally? - ts2.tech
Sana Biotech Stock Jumps A Whopping 35% After Eric Jackson Calls It ‘Next 100-Bagger Platform’ - Stocktwits
Sana Biotech Stock — The Next '100-Bagger'? - Benzinga
Using Ichimoku Cloud for Sana Biotechnology Inc. technicalsQuarterly Trade Summary & Daily Entry Point Alerts - newser.com
Sana Biotechnology stock higher after Eric Jackson touts 100-bagger potential - Yahoo Finance
Sana Biotech surges as Eric Jackson calls it a 100-bagger - MSN
Sana Biotech surges after Eric Jackson post (SANA:NASDAQ) - Seeking Alpha
Real time alert setup for Sana Biotechnology Inc. performance2025 Key Highlights & Detailed Earnings Play Strategies - newser.com
Will Sana Biotechnology Inc. stock outperform tech sector in 2025July 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com
Is Sana Biotechnology Inc. a candidate for recovery playQuarterly Portfolio Review & Proven Capital Preservation Methods - newser.com
How to escape a deep drawdown in Sana Biotechnology Inc.July 2025 Levels & Expert Verified Movement Alerts - newser.com
Visualizing Sana Biotechnology Inc. stock with heatmapsQuarterly Profit Report & Technical Entry and Exit Tips - newser.com
Sana Biotechnology (SANA): Evaluating Valuation Following Recent 47% Share Price Surge - Yahoo Finance
Sana Biotechnology's (SANA) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
How to build a dashboard for Sana Biotechnology Inc. stockGold Moves & Risk Controlled Stock Alerts - newser.com
Statistical indicators supporting Sana Biotechnology Inc.’s strength2025 Year in Review & Stock Portfolio Risk Control - newser.com
Evaluating Sana Biotechnology (SANA): Is Recent Momentum Reflected in Its Current Valuation? - Sahm
Sana Biotechnology (NASDAQ:SANA) Trading 9.1% HigherShould You Buy? - MarketBeat
Is a relief rally coming for Sana Biotechnology Inc. holdersTreasury Yields & AI Powered Market Entry Ideas - newser.com
Visual analytics tools that track Sana Biotechnology Inc. performanceJuly 2025 Update & Accurate Technical Buy Alerts - newser.com
Combining price and volume data for Sana Biotechnology Inc.2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com
Does Sana Biotechnology Inc. show high probability of reboundJuly 2025 Macro Moves & Free Expert Verified Stock Movement Alerts - newser.com
What data driven models say about Sana Biotechnology Inc.’s futureNew Guidance & Verified Momentum Stock Watchlist - newser.com
Certain Stock Options of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 6-OCT-2025. - MarketScreener
Certain Restricted Stock Units of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 6-OCT-2025. - MarketScreener
Sector ETF performance correlation with Sana Biotechnology Inc.Bear Alert & Verified Trade Idea Suggestions - newser.com
Certain Common Stock of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 6-OCT-2025. - MarketScreener
Sana Biotechnology, Inc. (NASDAQ:SANA) Receives $7.50 Consensus Price Target from Brokerages - Defense World
Sana Biotechnology Inc (SANA) 財務データ
収益
当期純利益
現金流量
EPS
1.84%
0.50%
大文字化:
|
ボリューム (24 時間):